Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011
Treatment of nasal polyposis in aspirine sensitive asthma Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001
Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Nonallergic rhinitis, sinonasal polyposis and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 108s Year: 2003
The clinical relationship of nasal polyposis to asthma and other pathologies in the French population Source: Eur Respir J 2003; 22: Suppl. 45, 114s Year: 2003
Aspirin-induced urticaria/angioedema without respiratory symptoms in severe asthmatics with nasal polyposis Source: Eur Respir J 2002; 20: Suppl. 38, 512s Year: 2002
Rhinitis, nasal polyposis and asthma: pathological aspects Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115 Year: 2001
Asthma and nasal polyposis: comparative evaluation of serum TNF-α and IL-4 Source: Eur Respir J 2004; 24: Suppl. 48, 262s Year: 2004
Asthma and nasal polyposis: comparative evaluation of serum TNF-α and IL-4 Source: Eur Respir J 2004; 24: Suppl. 48, 262s Year: 2004
Nasal polyposis and risk of the airway‘s inflammation development Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Treatment of inflammatory diseases of the nose Source: ISSN=1025-448x, ISBN=1-904097-19-21, page=165 Year: 2001
Impact of mepolizumab in severe asthma with nasal polyps Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps Source: Annual Congress 2011 - Epithelial cell biology Year: 2011
Nasal polyposis, analgesics intolerance and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 428s Year: 2001
Incidence of nasal polyposis and its association with the development of chronic bronchitis and/or emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002
The cytokines profile peculiarities in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 272s Year: 2001
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020